Min Deng

7PUBLICATIONS
14CO-AUTHORS
Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersTumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Aug 21, 2024
Hepatic arterial infusion chemotherapy-based conversion hepatectomy in responders versus nonresponders with hepatocellular carcinoma: a multicenter cohort study.

Min Deng, Chong Zhong, Dong Li

|Dec 16, 2022
Postoperative Adjuvant Hepatic Arterial Infusion Chemotherapy With FOLFOX in Hepatocellular Carcinoma With Microvascular Invasion: A Multicenter, Phase III, Randomized Study.

Shao-Hua Li, Jie Mei, Yuan Cheng

|Mar 28, 2022
Transarterial Infusion Chemotherapy with FOLFOX Could be an Effective and Safe Treatment for Unresectable Intrahepatic Cholangiocarcinoma.

Shaohua Li, Min Deng, Qiaoxuan Wang

|Sep 01, 2021
Expression pattern and prognostic value of N6-methyladenosine RNA methylation key regulators in hepatocellular carcinoma.

Min Deng, Lin Fang, Shao-Hua Li

|Jul 13, 2021
Relationship between PD-L1 expression, CD8+ T-cell infiltration and prognosis in intrahepatic cholangiocarcinoma patients.

Min Deng, Shao-Hua Li, Xu Fu

|Jul 02, 2021
High SGO2 Expression Predicts Poor Overall Survival: A Potential Therapeutic Target for Hepatocellular Carcinoma.

Min Deng, Shaohua Li, Jie Mei

Pageof 2

Frequent Collaborators

4 joint publications

Rongping Guo

2 joint publications

Jie Mei

1 joint publications

Wei Wei

1 joint publications

Yuan Cheng